Isofol announces its intention to list on Nasdaq First North Premier
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES.For a complete press release follow the link http://isofol.se/ipo For additional information, please contact:Anders Rabbe, CEO, Isofol, Mob: +46 70 764 65 00, Email: anders.rabbe@isofolmedical.comJan-Eric Österlund, Executive Chairman of the Board, Isofol, Mob: +44 77 853 68 155,